Generic semaglutide availability may lower barriers to affordable diabetes care
Generic semaglutide is starting to rewrite the economics of type 2 diabetes care in Canada. A new analysis published in ...
Tag: GLP-1 receptor agonists
Study finds slight increased risk of sudden vision loss with GLP-1 drugs
Glucagon-like peptide-1 (GLP-1) receptor agonists—widely prescribed for type 2 diabetes and obesity—may carry a small but clinically important safety signal, ...
Medicare Wegovy prescriptions soar following heart disease approval
Newly Expanded FDA Approval Spurs Significant Uptake in Medicare Coverage of Wegovy for Cardiovascular Risk Reduction Following a pivotal FDA ...
Stopping GLP-1RA Linked to Increased Depression and Anxiety in Type 2 Diabetes
A recent large-scale cohort study sheds new light on the psychiatric safety profile of glucagon-like peptide-1 receptor agonists (GLP-1RAs), widely ...
Obesity and Dietitian Groups Release Guidelines on Incretin Drug Use
Obesity treatment has entered a transformative era with the rise of incretin-based therapies (IBTs), notably GLP-1 receptor agonists, which have ...
GLP-1 Receptor Agonists Combined with Progestins and Their Impact on Endometrial Cancer Risk in Nonmalignant Uterine Conditions
A groundbreaking cohort study published recently in JAMA Network Open has revealed a promising therapeutic strategy to mitigate the risk ...
Exploring GLP-1 Agonists’ Role in Alcohol Use Disorder
Recent advancements in the field of addiction medicine have positioned GLP-1 receptor agonists as a promising therapeutic option for individuals ...
GLP-1 Agonist Trial in Large Vessel Occlusion
In a groundbreaking advancement at the intersection of endocrinology and neurology, a recent phase 2 randomized trial has unveiled promising ...
Study Finds GLP-1 Medications Significantly Reduce Mortality in Colon Cancer Patients
A groundbreaking study conducted by researchers at the University of California San Diego has unveiled compelling evidence suggesting that glucagon-like ...
Weight Loss Medications Safe for Patients with High Triglycerides: No Increased Risk of Pancreatitis or Cardiac Events
A groundbreaking new study conducted by researchers at Intermountain Health in Salt Lake City has delivered reassuring news for patients ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!